Feb 25, 2020 (KD Market Insights via COMTEX) -- Pharmaceutical Continuous Manufacturing Market by Product (Integrated Continuous Systems, Semicontinuous Systems, and Control & Software), Application (Final Drug Product Manufacturing and API Manufacturing), and End User (Pharmaceutical Companies, Contract Manufacturing Organizations, and Others): Global Opportunity Analysis and Industry Forecast, 2019-2026
The Global Pharmaceutical Continuous Manufacturing Market is expected to grow at a CAGR of 10.2% during the forecast period 2019-2026. As per the analyst, the market was valued at $393 million in the year 2018, and is anticipated to reach $855 million by the end of the year 2026.
GET FREE SAMPLE COPY @ https://www.reportocean.com/industry-verticals/sample-request?report_id=AMR305
Continuous manufacturing is generally known as Process Manufacturing. It is a production process that operates 24*7 and the raw materials used in the production line consist of slurries, powders, liquid and gases. The major reason behind continuous manufacturing is the material that are being perpetually processed and can experience heat treatment, mechanical treatment and chemical reactions. Specifically, pharmaceutical continuous manufacturing facilities work non-stop within the same facility and eliminate the hold times to produce qualitative product and address various causes of drugs recalls and shortages.
No comments:
Post a Comment